Authored by Marina Zhang via The Epoch Times Research led by scientists at Emory University in Atlanta found that while tetanus and influenza vaccines prompt the body to produce long-lived plasma cells that generate antibodies, COVID-19 vaccines do not. The study may explain why antibody protection from COVID-19 mRNA vaccines wanes so rapidly. The mRNA […]
Stefania Campana; Claudia De Pasquale; Giacomo Sidoti Migliore;, et. al. J Immunol (2022) 209 (4): 655–659. https://doi.org/10.4049/jimmunol.2200021 Abstract Proinflammatory monocytes play a preponderant role in the development of a cytokine storm causing fatal consequences in coronavirus disease 2019 (COVID-19) patients, highlighting the importance of analyzing in more detail monocyte distribution in these patients. In this study, […]
People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer. Authors: Ewen Callaway Journal: NATURE Many people who have been infected with SARS-CoV-2 will probably make antibodies against the virus for most of their lives. So suggest researchers […]
Sriya A. Reddy • Natalie Rivera Vargas • Aarushi Varshney • Olga Karasik, Published: July 10, 2024DOI: 10.7759/cureus.64267 Peer-Reviewed Abstract SARS-COVID-19 is known to manifest with a wide variety of symptoms, most of which are respiratory. Myalgias are a common symptom of COVID-19, but cases of severe virus-induced inflammatory muscle injury leading to rhabdomyolysis and polymyositis have also been reported. Here, we present and […]
Authors: Ortal Tuvali 1,†,Sagi Tshori 2,†,Estela Derazne 3,et. al. Abstract Myocarditis and pericarditis are potential post-acute cardiac sequelae of COVID-19 infection, arising from adaptive immune responses. We aimed to study the incidence of post-acute COVID-19 myocarditis and pericarditis. Retrospective cohort study of 196,992 adults after COVID-19 infection in Clalit Health Services members in Israel between March 2020 and […]
Via American Greatness, When Congressman Thomas Massie (R-KY) contacted officials from the Centers for Disease Control and Prevention (CDC) in December of 2020, he wanted to know if taking the newly released Covid vaccine would benefit him, since he’d already contracted the illness. After reading the scientific studies himself, and seeing no benefit, Massie contacted […]
Natsuki Anada • Yoshinobu Nakayama • Jun Takeshita • Kyoko Kageyama • Hiroatsu Sakamoto • Takahiko Kamibayashi • Yasufumi Nakajima 2024, DOI: 10.7759/cureus.63736 Abstract Introduction The efficient clearance of bacteria by macrophages is crucial for the timely resolution of inflammation. In this study, we investigated the role of microRNA-21 (miR-21)-induced phagocytosis and its intracellular signaling pathways in human macrophages in vitro. Methods Human peripheral blood mononuclear cells (PBMCs) were […]
Carlos Garcia-Prieto, Eva Musulen, Veronica Davalos, et. al.doi: https://doi.org/10.1101/2024.07.03.601404 00010010 Abstract Severe Coronavirus disease 2019 (COVID-19) induces heterogeneous and progressive diffuse alveolar damage (DAD) highly disrupting lung tissue architecture and homeostasis, hampering disease management and leading to fatal outcomes. Characterizing DAD pathophysiology across disease progression is of ultimate importance to better understand the molecular and cellular features driving different DAD patterns and […]
By Isabella Cueto, 2024 Stat Reporting Remember when we thought Covid was a two-week illness? So does Michael Peluso, assistant professor of medicine at the University of California, San Francisco. He recalls the rush to study acute Covid infection, and the crush of resulting papers. But Peluso, an HIV researcher, knew what his team excelled at: following […]
Authors: Anna Cervantes-Arslanian MD,K. H. Vincent Lau MD,Pria Anand MD, et. al. Annals of Neurology Volume 88, Issue 2 p. 211-214 Introduction In response to the coronavirus disease 2019 (COVID-19) pandemic, the scientific community has made great efforts to accelerate its process for knowledge synthesis and dissemination, including expedited journal peer review,1 open source platforms for quick […]